Cancer Survival Insights

Median survival rates for metastatic cancer have improved over the decades, with treatments extending life by a few months. However, despite advancements, overall survival rates for solid epithelial tumors remain stagnant at 0%. This stark contrast highlights the complexities of cancer treatment and the ongoing challenges faced in achieving long-term survival.